Humana Inc. $HUM Shares Acquired by State of Alaska Department of Revenue

Key Points

• The State of Alaska Department of Revenue increased its stake in Humana Inc. by 20.8%, now holding 17,072 shares worth approximately $4.17 million.
• Humana reported a 9.6% increase in quarterly revenue year-over-year, totaling $32.39 billion, although the earnings per share (EPS) missed estimates by $0.05.
• The company declared a quarterly dividend of $0.885 per share, representing an annualized dividend of $3.54 and a yield of 1.4%.

State of Alaska Department of Revenue lifted its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 20.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,072 shares of the insurance provider's stock after acquiring an additional 2,935 shares during the period. State of Alaska Department of Revenue's holdings in Humana were worth $4,173,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of HUM. Cary Street Partners Investment Advisory LLC raised its stake in Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after purchasing an additional 46 shares during the period. Riverview Trust Co acquired a new stake in shares of Humana during the 1st quarter worth approximately $34,000. Garde Capital Inc. acquired a new stake in shares of Humana during the 1st quarter worth approximately $36,000. Zions Bancorporation National Association UT purchased a new stake in shares of Humana during the 1st quarter valued at approximately $37,000. Finally, Whipplewood Advisors LLC lifted its holdings in Humana by 639.1% in the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock valued at $45,000 after acquiring an additional 147 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Price Performance

HUM stock opened at $255.06 on Tuesday. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $30.68 billion, a P/E ratio of 19.57, a PEG ratio of 1.50 and a beta of 0.44. The business has a 50 day simple moving average of $272.54 and a 200-day simple moving average of $257.43. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $324.38.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter last year, the company earned $6.96 EPS. The firm's revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities analysts anticipate that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. Humana's dividend payout ratio (DPR) is currently 27.17%.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. Morgan Stanley cut their target price on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research note on Thursday, July 31st. Robert W. Baird cut their price objective on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Piper Sandler reduced their price objective on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a report on Thursday, July 31st. Bank of America increased their target price on shares of Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research note on Tuesday, September 2nd. Finally, Evercore ISI started coverage on shares of Humana in a research note on Monday, September 22nd. They issued an "in-line" rating and a $295.00 price target on the stock. Seven equities research analysts have rated the stock with a Buy rating and seventeen have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $289.50.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.